Kauser M. Akhoon

Array ( [id] => 11106261 [patent_doc_number] => 20160303231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/101409 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17253 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10247346 [patent_doc_number] => 20150132342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'NOVEL IMMUNE ACTIVATORS: SUBSTITUTE 4-AMINOQUINAZOLINES' [patent_app_type] => utility [patent_app_number] => 14/536146 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36805 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12037567 [patent_doc_number] => 09815784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'CC-1065 analogs and their conjugates' [patent_app_type] => utility [patent_app_number] => 14/526462 [patent_app_country] => US [patent_app_date] => 2014-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 61061 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14526462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10056274 [patent_doc_number] => 09095614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Tamper resistant dosage forms' [patent_app_type] => utility [patent_app_number] => 14/515855 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 66024 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044436 [patent_doc_number] => 09084816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Tamper resistant dosage forms' [patent_app_type] => utility [patent_app_number] => 14/515924 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 66012 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10056275 [patent_doc_number] => 09095615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Tamper resistant dosage forms' [patent_app_type] => utility [patent_app_number] => 14/515921 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 66007 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9836434 [patent_doc_number] => 20150028512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'TAMPER RESISTANT DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 14/515857 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 65978 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240479 [patent_doc_number] => 20150125474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'PROTEIN-POLYMER-DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/512275 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 60795 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864690 [patent_doc_number] => 20150044708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'Methods for Detecting Oncofetal Fibronectin' [patent_app_type] => utility [patent_app_number] => 14/507079 [patent_app_country] => US [patent_app_date] => 2014-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 165218 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14507079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917152 [patent_doc_number] => 20150072357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'Cholesteryl Succinyl Silane Bound Proteins and Methods For Producing and Using the Same' [patent_app_type] => utility [patent_app_number] => 14/478235 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8658 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916784 [patent_doc_number] => 20150071989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'LIPOSOMES FOR HEMATOLOGICAL TUMORS' [patent_app_type] => utility [patent_app_number] => 14/478643 [patent_app_country] => US [patent_app_date] => 2014-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16250 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11323871 [patent_doc_number] => 20160354482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING MACROLIDE DIASTEREOMERS, METHODS OF THEIR SYNTHESIS AND THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 14/913965 [patent_app_country] => US [patent_app_date] => 2014-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10840 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202013 [patent_doc_number] => 20150087001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'METHODS FOR PHENOTYPING OF INTACT WHOLE TISSUES' [patent_app_type] => utility [patent_app_number] => 14/447607 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28177 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938920 [patent_doc_number] => 20140341940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'IMMUNOMODULATOR FOR THE TREATMENT OF CANCEROUS TUMORS IN THE EPITHELIAL TISSUE LINING SURFACES INSIDE OR OUTSIDE BODY ORGANS' [patent_app_type] => utility [patent_app_number] => 14/444436 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24640 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858412 [patent_doc_number] => 20150038430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 14/325933 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 34983 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960426 [patent_doc_number] => 20140363454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'Antibody-Drug Conjugates, Compositions and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/298798 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30776 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11922932 [patent_doc_number] => 09790503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'VHZ for diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/276203 [patent_app_country] => US [patent_app_date] => 2014-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 21 [patent_no_of_words] => 35083 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14276203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11921004 [patent_doc_number] => 09788564 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Compositions containing non-polar compounds' [patent_app_type] => utility [patent_app_number] => 14/271847 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 63276 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9642015 [patent_doc_number] => 20140220126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE' [patent_app_type] => utility [patent_app_number] => 14/249965 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18512 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670455 [patent_doc_number] => 20140234318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'TUMOR SPECIFIC OLIGOSACCHARIDE EPITOPES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/223346 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26814 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14223346 [rel_patent_id] =>[rel_patent_doc_number] =>)